SciELO Analytics (Beta)
Mexico
Annals of Hepatology (1665-2681)
Documents filters
Publishing year


Subject area


Language


Top 100 articles by number of accesses

article html pdf epdf abstract total
Management Strategies for Liver Fibrosis 1753 331 0 64 2148
What is Changing in Indications and Treatment of Focal Nodular Hyperplasia of the Liver. Is There any Place for Surgery? 932 88 0 46 1066
Association Between Hepatitis B Virus and Chronic Kidney Disease: a Systematic Review and Meta-analysis 729 178 0 43 950
Drug Induced Liver Injury at a Tertiary Hospital in India: Etiology, Clinical Features and Predictors of Mortality 610 93 0 48 751
Testosterone, Sex Hormone-Binding Globulin and Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis 634 69 0 45 748
Intrahepatic Cholestasis of Pregnancy: New Diagnostic Insights 569 80 0 4 653
Minimal Hepatic Encephalopathy in Cirrhosis- How Long to Treat? 496 85 0 43 624
Effect of Treatment with Direct Acting Antiviral on Glycemic Control in Patients with Diabetes Mellitus and Chronic Hepatitis C 424 99 0 73 596
Combination of Ledipasvir and Sofosbuvir for Treatment of Hepatitis C Virus Genotype 1 Infection: Systematic Review and Meta-Analysis 355 94 0 131 580
Liver Transplantation for Hepatocellular Carcinoma: Impact of Wait Time at a Single Center 480 53 0 44 577
The Prevalence of Parkinson Disease Among Patients With Hepatitis C Infection 454 71 0 50 575
Perspectives on NASH Histology: Cellular Ballooning 439 57 0 49 545
Curing Chronic Hepatitis C: A Cost Comparison of the Combination Simeprevir Plus Sofosbuvir vs. Protease-Inhibitor-Based Triple Therapy 394 97 0 47 538
Intrahepatic, Perihilar and Distal Cholangiocarcinoma: Management and Outcomes 429 50 0 38 517
Ursodeoxycholic Acid Therapy in Patients with Primary Biliary Cholangitis with Limited Liver Transplantation Availability 380 57 0 64 501
Sarcopenia Predicts Reduced Survival in Patients with Hepatocellular Carcinoma at First Diagnosis 373 77 0 42 492
Differences in Hepatic Expression of Iron, Inflammation and Stress-Related Genes in Patients with Nonalcoholic Steatohepatitis 374 51 0 47 472
Lamivudine, Entecavir, or Tenofovir Treatment of Hepatitis B Infection: Effects on Calcium, Phosphate, FGF23 and Indicators of Bone Metabolism 366 41 0 50 457
Sofosbuvir and Daclatasvir in Mono-and HIV-coinfected Patients with Recurrent Hepatitis C After Liver Transplant 339 61 0 56 456
Clinical Impact of Portal Vein Thrombosis Prior to Liver Transplantation: A Retrospective Cohort Study 353 48 0 53 454
Persistence of Virologic Response after Liver Transplant in Hepatitis C Patients Treated with Ledipasvir / Sofosbuvir Plus Ribavirin Pretransplant 306 75 0 54 435
A New Paradigm in Gallstones Diseases and Marked Elevation of Transaminases: An Observational Study 325 46 0 48 419
High Clinical Manifestation Rate in an Imported Outbreak of Hepatitis E Genotype 1 Infection in a German Group of Travellers Returning from India 310 57 0 47 414
Combination of TACE and Sorafenib Improves Outcomes in BCLC Stages B/C of Hepatocellular Carcinoma: A Single Centre Experience 326 30 0 50 406
Observational Cohort Study of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt (TIPS) 298 62 0 44 404
Surveillance for Hepatocellular Carcinoma Reduces Mortality: an Inverse Probability of Treatment Weighted Analysis 291 54 0 53 398
The Utilization of Palliative Care Services in Patients with Cirrhosis who have been Denied Liver Transplantation: A Single Center Retrospective Review 264 59 0 63 386
Cost-Effectiveness and Clinical Impact of Antiviral Strategies of HBeAG-Positive and Negative Chronic Hepatitis B 259 76 0 48 383
Conversion to Mycophenolate Mofetil Monotherapy in Liver Recipients: Calcineurin Inhibitor Levels are Key 292 47 0 42 381
Utility and Safety of Tolvaptan in Cirrhotic Patients with Hyponatremia: a Prospective Cohort Study 298 41 0 38 377
Interaction of Gender and Hepatitis C in Risk of Chronic Renal Failure After Liver Transplantation 288 34 0 50 372
A Summary of the 6th International Conference on Coagulation in Liver Disease: Discussion, Debate, Deliberations 298 54 0 13 365
Cancer Stem Cells are Depolarized Relative to Normal Stem Cells Derived from Human Livers 269 43 0 50 362
Complications of Liver Resection in Geriatric Patients 272 46 0 39 357
Risk Factors for Prognosis of Hepatocellular Carcinoma After Curative Resection In Patients with Low Hepatitis B Viral Load 253 53 0 48 354
A Rare BSEP Mutation Associated with a Mild Form of Progressive Familial Intrahepatic Cholestasis Type 2 253 54 0 41 348
Transient Elastography vs.Aspartate Aminotransferase to Platelet Ratio Index in Hepatitis C: A Meta-Analysis 252 45 0 42 339
Aplastic Anemia and Severe Myelosuppression with Boceprevir or Simeprevir-Containing Hepatitis C Virus Treatment 239 45 0 53 337
Recurrent Hyperammonemia After Abernethy Malformation Type 2 Closure: a Case Report 252 40 0 45 337
Hepatitis B and NAFLD: Lives Crossed 249 35 0 49 333
A Randomized Controlled Trial of Procedural Techniques for Large Volume Paracentesis 258 26 0 47 331
Effects of Interleukin-4 and Interleukin-12b Gene Polymorphisms on Hepatitis B Virus Vaccination 232 55 0 39 326
Age-Standardized Mortality Rates Related to Cirrhosis in Brazil from 2000 to 2012: A Nationwide Analysis 229 40 0 47 316
Cholangiohydatidosis: an Infrequent Cause of Obstructive Jaundice and Acute Cholangitis 234 37 0 45 316
Graft Calcification Caused by a Torsion of the Hepatic Vein after a Living-Related Donor Liver Transplantation 243 31 0 37 311
Practical Considerations of Real Life of Hepatocellular Carcinoma in a Tertiary Center of Brazil 229 29 0 44 302
Acute Hepatitis E Mimicking a Flare of Disease in a Patient with Chronic Autoimmune Hepatitis 220 43 0 36 299
The Direct-Acting Antivirals for Hepatitis C Virus and the Risk for Hepatocellular Carcinoma 203 36 0 53 292
Daclatasvir Plus Asunaprevir Dual Therapy for Chronic HCV Genotype 1b Infection: Results of Turkish Early Access Program 221 35 0 30 286
The Impact of Early Dermatologic Events in the Survival of Patients with Hepatocellular Carcinoma Treated with Sorafenib 206 19 0 52 277
Ongoing Alcohol Consumptions Counteracts the Benefits of Sustained Virological Response in Patients with Well Compensated Hepatitis C Cirrhosis: an Observational Study 227 33 0 16 276
High Prevalence of ITPA Alleles Associated with Ribavirin-Induced Hemolytic Anemia Among Mexican Population 170 48 0 58 276
Identification of Matrix Metalloproteinase-2 and 9 as Biomarker of Intrahepatic Cholestasis of Pregnancy 183 44 0 46 273
Viral Outcome in Patients with Occult HBV Infection or HCV-Ab Positivity Treated for Lymphoma 176 36 0 52 264
MRE in NAFLD: Promising but Further Validation is Required 177 35 0 48 260
Drug-induced Liver Injury Caused by Ipragliflozin Administration with Causality Established by a Positive Lymphocyte Transformation Test (LTT) and the Roussel Uclaf Causality Assessment Method (RUCAM): A Case Report 168 20 0 56 244
GNPAT rs11558492 is not a Major Modifier of Iron Status: Study of Italian Hemochromatosis Patients and Blood Donors 152 37 0 44 233
Prospective Indian Study of DILI with Confirmed Causality Using the Roussel Uclaf Causality Assessment Method (RUCAM): A Report of Excellence 199 31 0 2 232
Persistence of Virologic Response after Liver Transplant in Hepatitis C Patients Treated with Ledipasvir/Sofosbuvir Plus Ribavirin Pretransplant 196 33 0 2 231
Metastatic Lymphoepithelioma-like Hepatocellular Carcinoma: a Potential Diagnostic Pitfall and Demonstration of Pd-l1 Expression 152 34 0 39 225
Celebrating Fifteen Years of Annals of Hepatology Publication: The International, Open Access, Clinical Journal Devoted to Liver Diseases 190 19 0 14 223
Spontaneous Resolution of Multiple Hepatic Masses: Hepatic Inflammatory Pseuduotumor 192 28 0 2 222
Liver Transplantation as Cure of Hepatocellular Carcinoma: It is not a Matter of Time, it is a Matter of Tumor Biology 178 40 0 2 220
Hispanic Ethnicity is Associated with Increased Morbidity and Mortality in Patients with Alcoholic Liver Disease 170 29 0 19 218
Hepatitis B Reactivation or Hepatitis C Exacerbation in Patients with Hematological Malignancies 171 41 0 4 216
Foamy Histiocyte-Like Hepatocellular Carcinoma (HCC): A New Variant of HCC? 181 25 0 4 210
Joint Society Statement for elimination of viral hepatitis 109 73 0 19 201
Right Hepatic Lobe Resection and Thrombocytopenia 123 31 0 35 189
Reply to “HbAlc Levels as a Parameter of Glycemic Control in Patients with Liver Cirrhosis” 146 25 0 2 173
In memoriam. Prof. Juan Rodés Teixidor 127 18 0 4 149
HbAlc Levels as a Parameter of Glycemic Control in Patients with Liver Diseases 116 31 0 2 149
Ironing out Steatohepatitis 99 19 0 18 136
This tool is under development and it is available in Beta Test version
This tool is under development and it was published with the objective to test the usage and performance. All the indicators are real and they are gradually being loaded. Slowness and out of service problems may occur in this version.
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.